Small Caps Today
Inside Boeing’s $36 Billion Comeback: How the Aviation Giant Plans To Soar Again!
Dec 26, 2024

Inside Boeing’s $36 Billion Comeback: How the Aviation Giant Plans To Soar Again!

6' read
From Beyoncé To NFL: Can Netflix Cement Its Sports Streaming Legacy?
Dec 26, 2024

From Beyoncé To NFL: Can Netflix Cement Its Sports Streaming Legacy?

6' read
Jan 06, 2025

Powering the Future: How EZFill Holdings Inc. is Leading the Energy Transition

The energy landscape is undergoing a massive transformation. Traditional gas stations are dying off, while the demand for sustainable and reliable energy solutions is rapidly increasing. This shift presents both a significant challenge and a massive opportunity, one that EzFill Holdings Inc. (NASDAQ: EZFL) is strategically positioned to lead.

11' read
Could Lionsgate Be Hollywood’s Next Big Buy? Top Reasons It’s on Every Investor’s Radar
Dec 24, 2024

Could Lionsgate Be Hollywood’s Next Big Buy? Top Reasons It’s on Every Investor’s Radar

4' read
Could Logility Be the Next Big Supply Chain Tech Buyout? Here’s Why Investors Should Pay Attention
Dec 24, 2024

Could Logility Be the Next Big Supply Chain Tech Buyout? Here’s Why Investors Should Pay Attention

5' read
November Retail Sales Beat Expectations, Showing a Strong Start to Holiday Shopping Season
Dec 24, 2024

November Retail Sales Beat Expectations, Showing a Strong Start to Holiday Shopping Season

4' read
Stock Market Today: Dow Eyes Rebound Amid Longest Losing Streak Since 1978
Dec 24, 2024

Stock Market Today: Dow Eyes Rebound Amid Longest Losing Streak Since 1978

4' read
Stock Market Today: Dow Eyes Rebound Amid Longest Losing Streak Since 1978
Dec 24, 2024

Stock Market Today: Dow Eyes Rebound Amid Longest Losing Streak Since 1978

4' read
Stock Market Today: Stocks Bounce Back After Fed-Driven Sell-Off
Dec 24, 2024

Stock Market Today: Stocks Bounce Back After Fed-Driven Sell-Off

4' read

Business & Market Movers

Powering the Future: How EZFill Holdings Inc. is Leading the Energy Transition

Inside Boeing’s $36 Billion Comeback: How the Aviation Giant Plans To Soar Again!

Inside Boeing’s $36 Billion Comeback: How the Aviation Giant Plans To Soar Again!

·Dec 26, 2024
From Beyoncé To NFL: Can Netflix Cement Its Sports Streaming Legacy?

From Beyoncé To NFL: Can Netflix Cement Its Sports Streaming Legacy?

·Dec 26, 2024
Could Lionsgate Be Hollywood’s Next Big Buy? Top Reasons It’s on Every Investor’s Radar

Could Lionsgate Be Hollywood’s Next Big Buy? Top Reasons It’s on Every Investor’s Radar

·Dec 24, 2024
Could Logility Be the Next Big Supply Chain Tech Buyout? Here’s Why Investors Should Pay Attention

Could Logility Be the Next Big Supply Chain Tech Buyout? Here’s Why Investors Should Pay Attention

·Dec 24, 2024

Stock Market Today: Dow Eyes Rebound Amid Longest Losing Streak Since 1978

Breaking News

s
scdadmin
·Jan 30, 2024

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”

Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.

3' read
Amesite Launches Implicit Bias Training with Expert Larry Davis Jr.

Amesite Launches Implicit Bias Training with Expert Larry Davis Jr.

scdadmin·Jan 30, 2024
Stock Market Today: Mixed Signals Keep Stocks Muted

Stock Market Today: Mixed Signals Keep Stocks Muted

scdadmin·Jan 04, 2024
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

scdadmin·Dec 15, 2023
COP28 Reshapes Oil: Navigating Energy Transition

COP28 Reshapes Oil: Navigating Energy Transition

scdadmin·Dec 14, 2023

Healthcare & Biotech

Dec 04, 2024

The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics

On December 3, 2024, the company announced groundbreaking results for its lead drug candidate, JANX007, a tumor-activated T-cell engager targeting advanced-stage prostate cancer.

5' read
SUPPER CHANGE YOUR PLANNING POWERS

Join our newsletter

Read and share new perspectives on just about any topic. Everyone’s welcome.
  • 01Create a free account
  • 02Write your story

Tech & Energy

Dec 20, 2024

Microsoft Is Betting Big on NVIDIA GPUs — But Will Custom Chips Save Its AI Ambitions?

Microsoft has secured nearly half a million Nvidia GPUs in 2024 alone, surpassing rivals Google, Amazon, and Meta given its urgency in scaling its AI infrastructure amid fierce competition.

5' read